Lung Cancer, Non-Small Cell : Related News

On Our Blog

Pictured: Marc Ladanyi & Snjezana Dogan
Study Suggests Women Are More Susceptible to Smoking-Related Lung Cancers

A genetic analysis of tumors suggests women are more susceptible than men to the most common form of lung cancer.

November 9, 2012
Pictured: Manjit Bains
Latest Information about Lung Cancer Care at Memorial Sloan-Kettering

In our recently updated guides to non-small cell and small-cell lung cancers, you can learn about diagnosis, treatment, follow-up care, lung cancer experts, and clinical trials at Memorial Sloan-Kettering.

June 6, 2012
Pictured: Peter Bach
Pulmonary Specialist Peter Bach Discusses New Findings on Benefits of CT Screening for Lung Cancer

In an interview, Dr. Bach talks about research showing that CT screening may prevent one in five cancer deaths for people at a very high risk of developing lung cancer.

May 21, 2012
Pictured: Paul Paik
Testing for Mutations Identified in Squamous Cell Lung Cancer Tumors Helps Personalize Treatment

Memorial Sloan-Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.

May 17, 2012
Pictured: Jedd Wolchok & Paul Chapman
Memorial Sloan-Kettering Physician-Scientists Present Significant Clinical Cancer Research Advances at ASCO Annual Meeting

In an extraordinary demonstration of excellence, five Memorial Sloan-Kettering physician-scientists were selected to participate in the press program at the 2011 American Society of Clinical Oncology annual meeting, held June 3-7 in Chicago.

July 1, 2011
New Technology Will Improve Molecular Testing of Tumors for Patients

Memorial Sloan-Kettering has made an important step forward in efficiently diagnosing gene mutations in patients’ cancers on an individual basis.

June 1, 2010

Related Media Coverage

Mark Kris
Tumors In Majority Of Patients With Advanced Lung Cancer Found To Have Genetic Mutations That Can Be Treated With Targeted Therapies

A new study detected one of ten such mutations in 54 percent of the 516 lung cancer patients tested at diagnosis. The results enabled doctors to select the most appropriate drug designed to block the identified mutation and choose other treatment options for those patients whose tumors did not have a mutation.

June 4, 2011
Research Reveals What Drives Lung Cancer's Spread

A new study by researchers at Memorial Sloan-Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.

July 2, 2009

On Cancer

News and Insights from
Memorial Sloan-Kettering
Read Our Blog »

Center News

Pictured: Center News, April 2013
Read Our Magazine »

Subscribe to Our E-newsletter

Get the latest information about cancer care.